0 CHECKOUT

Presale: Galileo Euro ABS CDO I Ltd. Aug 07

  • ID: 2031854
  • August 2007
  • Standard & Poors

Abstract
Standard & Poor's Ratings Services has assigned preliminary credit ratings to the €690 million secured floating-rate notes to be issued by Galileo Euro ABS CDO I Ltd. Galileo Euro ABS CDO I will also issue an unrated tranche totaling €39 million. Standard & Poor's ratings address the likelihood that the reference portfolio, when subjected to stressed conditions, can generate adequate cash flow to meet contractual payments of interest and principal given the level of defaults expected for the portfolio at a particular rating level. The note proceeds will be placed in the collateral account, and may be invested in eligible investments thereafter. The reference portfolio is expected to be 100% ramped up at closing, and the weighted-average life is expected...

Companies mentioned in this report are:
- Deutsche Bank AG

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown

- Deutsche Bank AG

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: This Credit Rating Report will be emailed to you.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.